Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Novel agents and new therapeutics in castration-resistant prostate cancer.

Novel agents and new therapeutics in castration-resistant prostate cancer. Curr Opin Oncol. 2011 May; 23(3):290-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.